Jonathan Rockoff is the Health Business editor at The Wall Street Journal, managing a team that reports on pharmaceutical and biotechnology companies, health insurers and hospitals. During the ...

Ed Ballard covers climate change and the energy transition for The Wall Street Journal from London. His weekly column in the ...

Emerald Finance Limited has partnered with PARK NEST HOTELS PVT LTD, a company having its registered office address at IVY ...

Dutch biotech Avidicure has launched with $50 million in seed financing to support development of a novel class of ...

D2 Collins LLC, an affiliate of the D2 Organization, has finalized the sale of a 48-acre logistics park development site in Carneys Point, NJ, to EQT Real ...

The firm, which has once again topped the latest AmLaw 100 ranking, has secured a series of sub-one billion dollar U.K. and ...

There’s a lot to be optimistic about in the Energy sector as 2 analysts just weighed in on HF Sinclair Corporation (DINO – Research Report) and ...

AVC-Boosters are designed as dual agonistic antibodies to safely deliver targeted and potent monotherapy with broad application in oncology Lead product AVC-S-101 is a TROP2-targeting booster being ...

The firm, which has once again topped the latest Am Law 100 ranking, has secured a series of sub-one billion dollar U.K. and ...

Investors poured millions into these startups working in legal tech, cybersecurity, agent testing, and productivity.

EQT Corporation EQT reported first-quarter 2024 adjusted earnings from continuing operations of $1.18 per share, which beat ...